Cardiology (all articles)
Meta-analysis: Prevalence of postural hypotension in primary, community and institutional care
22 Jan, 2021 | 08:09h | UTC
Meta-Analysis: Low-intensity warfarin may be an option for patients under 65 years of age with non-valvular atrial fibrillation
21 Jan, 2021 | 00:57h | UTCMeta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation – The American Journal of Cardiology (link to abstract – $ for full-text)
Randomized trial: No benefit from discontinuing ACE Inhibitors and ARBs in patients admitted with COVID-19
20 Jan, 2021 | 01:55h | UTCCommentary: Discontinuing vs. Continuing ACEIs, ARBs in Patients Admitted With COVID-19 – American College of Cardiology
Related study (study and commentary): Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19
After return of spontaneous circulation in patients with out-of-hospital cardiac arrest, too early ECG acquisition (7 minutes or less) is associated with false-positive findings for STEMI
19 Jan, 2021 | 01:44h | UTCCommentary: Delaying Electrocardiography in Cardiac Arrest: A Pause for the Cause – JAMA Network Open
Meta-Analysis: After transcatheter aortic valve implantation, Aspirin alone is a better choice than dual antiplatelet therapy
19 Jan, 2021 | 01:34h | UTCMeta-Analysis Comparing the Safety and Efficacy of Single vs. Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients. – American Journal of Cardiology (link to abstract – $ for full-text)
Returning to physical activity after Covid-19
17 Jan, 2021 | 22:19h | UTCReturning to physical activity after covid-19 – The BMJ
Commentary: Returning to physical activity after a Covid-19 infection – Medical Centre
Commentaries on Twitter
"Returning to #PhysicalActivity after #COVIDー19 should be gradual, individualised, and based on subjective tolerance of the activity.".#exercise #rehab
⛹️♀️?⚽??️?️♂️?♀️?♂️?♀️??
HT- @bmj_latesthttps://t.co/GnqwCBkZRN pic.twitter.com/k4nsDI6ApU
— Christopher Tuckett (@HealthPhysio) January 15, 2021
Professional experience suggests that after mild suspected covid-19 a proportion of people experience a prolonged recovery. What are the risks of physical activity after covid-19 and how to know if a patient can safely return to physical exercise?https://t.co/19Cfi4p5Ck
— The BMJ (@bmj_latest) January 11, 2021
Contradicting early research, 2 new MRI studies show lower degrees of myocarditis in athletes recovered from COVID-19
17 Jan, 2021 | 22:14h | UTCStudy 1: Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging – JAMA Cardiology AND Commentaries: Screening Athletes for Myocarditis With Cardiac Magnetic Resonance Imaging After COVID-19 Infection—Lessons From an English Philosopher – JAMA Cardiology AND Low Prevalence of Myocarditis in Athletes Recovered from COVID-19 – docwire News
Study 2: Cardiac MRI Shows Lower Degrees of Myocarditis in Athletes Recovered From COVID-19 – Circulation AND Commentaries: Cardiac MRI shows lower degrees of myocarditis in athletes recovered from COVID-19 – Vanderbilt University Medical Center AND Heart damage less common among athletes who recover from COVID-19 than previously believed, cardiologists find – Cardiovascular Business
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic
17 Jan, 2021 | 22:01h | UTCRemote monitoring in heart failure: current and emerging technologies in the context of the pandemic – Heart (free for a limited period)
Cardiovascular complications of opioid use: JACC state-of-the-art review
17 Jan, 2021 | 22:04h | UTC
Study: Vaping combined with smoking may be as harmful as smoking cigarettes alone
17 Jan, 2021 | 21:53h | UTCCommentaries: Vaping combined with smoking is likely as harmful as smoking cigarettes alone, study finds – American Heart Association AND CVD Biomarker Levels Up for Dual Use of E-Cigarettes, Cigarettes – Physician’s Weekly
Consensus statement: Diagnosis, treatment, and follow-up of heart failure patients by general practitioners
17 Jan, 2021 | 21:48h | UTC
Systematic review: Insufficient evidence to recommend Trypanocidal drugs for late-stage, symptomatic Chagas disease
17 Jan, 2021 | 21:44h | UTCSummary: Trypanocidal drugs for late-stage, symptomatic Chagas disease – Cochrane Library
Review: Anesthetic management of conduction disturbances following transcatheter aortic valve replacement
17 Jan, 2021 | 21:39h | UTC
Commentary on Twitter
Conduction disturbances remain common following transcatheter aortic valve replacement (#TAVR). Anesthetic Management of Conduction Disturbances following Transcatheter Aortic Valve Replacement: A Review of the 2020 ACC Expert Consensus Decision Pathway. https://t.co/s7e2MEJFAI pic.twitter.com/VqUcdUEehp
— Journal of Cardiothoracic and Vascular Anesthesia (@JCVAonline) December 26, 2020
Meta-analysis of randomized trials: SGLT-2 inhibitors and GLP-1 receptor agonists reduce cardiovascular and renal outcomes in type 2 diabetes
15 Jan, 2021 | 08:41h | UTCCalculator based on the results: interactive decision support tool for outcomes
Cohort study: Even small amounts of alcohol consumption linked to increased risk of atrial fibrillation
15 Jan, 2021 | 08:40h | UTCEditorial: Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance
Study: Despite recommendations, less than 2 percent of patients with treatment-resistant hypertension were tested for primary aldosteronism in a large U.S. cohort
14 Jan, 2021 | 01:55h | UTCTesting for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Primary Aldosteronism Testing Rare in Treatment-Resistant HTN – HealthDay AND Primary Aldosteronism Testing Rare for Patients with Resistant Hypertension – NEJM Journal Watch
Commentary from the author on Twitter (thread – click for more)
Our new study is out in @AnnalsofIM w/@BhallaResearch @thebyrdlab @johnleppert! ?https://t.co/UCrAD4ed0w
We asked: Are patients w/treatment resistant HTN being appropriately tested for primary aldosteronism (PA) & managed w/mineralocorticoid receptor antagonists (MRAs)? 1/ pic.twitter.com/jO4cqA37sD
— Jordy Cohen, MD, MSCE (@jordy_bc) December 28, 2020
2021 ACC Expert consensus decision pathway for optimization of heart failure treatment
13 Jan, 2021 | 02:01h | UTCCommentary: ACC Issues Updated Guidance For Managing Patients With HFrEF – American College of Cardiology
2021 ACC Expert Consensus: Same-day discharge after percutaneous coronary intervention
13 Jan, 2021 | 02:05h | UTCCommentaries: 2021 ACC Expert Decision Pathway on Same-Day Discharge After PCI – American College of Cardiology AND Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan – TCTMD AND Same-Day Discharge After PCI: ACC Expert Consensus Decision Pathway – Cardiology Advisor AND Ticking all the right boxes for same-day discharge PCI – MDedge Cardiology
Case series: Safety of same‐day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID‐19 era
13 Jan, 2021 | 02:03h | UTCCommentary: Pandemic Prompts Closer Look at Same-Day Discharge After TAVI – TCTMD
Commentary on Twitter
With dwindling hospital capacity from #COVID19, study of safety of same‐day discharge after #TAVR @emoryhealthcare available via @CCIJournal. SDD after uncomplicated #TAVR in selected patients may open beds & prevent unnecessary CV morbidity. https://t.co/fuTdVUrFu5
— Chandan Devireddy MD MBA (@drdevireddy) December 31, 2020
HEAR or HEART Pathway – Can We Drop Troponin?
13 Jan, 2021 | 01:59h | UTCHEAR or HEART Pathway – Can We Drop Troponin? – Journal Feed
Original Study: Identification of very low-risk acute chest pain patients without troponin testing – Emergency Medicine Journal
Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19
12 Jan, 2021 | 01:59h | UTC
NEW Research—renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with #COVID19
RCT from Julio Chirinos & colleagues https://t.co/ZNfqJ0NsRK pic.twitter.com/Kpg6xSsWKl
— The Lancet Respiratory Medicine (@LancetRespirMed) January 8, 2021
Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: New risk factors, concepts and controversies
12 Jan, 2021 | 01:47h | UTC
ACC Consensus: Anticoagulation and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing PCI or with atherosclerotic cardiovascular disease
12 Jan, 2021 | 01:50h | UTCCommentaries: ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE – TCTMD AND ACC Issues Clinical Guidance For Antithrombotic Therapy in Patients With AFib or VTE Undergoing PCI or With ASCVD – American College of Cardiology
Commentary on Twitter
ICYMI: @ACCinTouch released clinical guidance for antithrombotic therapy in pts w/ #AFib/#VTE undergoing PCI or w/ #ASCVD. Doc aims to serve as a framework for decision-making among pts requiring concomitant use of an anticoagulant & antiplatelet therapy. https://t.co/PqinRIvLY9 pic.twitter.com/prbnbBPG5L
— JACC Journals (@JACCJournals) December 29, 2020
Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms
12 Jan, 2021 | 01:38h | UTCAssociation of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)
Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly
Systematic Review: “For the general population of persons with elevated blood pressure, the benefits of trying to achieve a lower blood pressure target rather than a standard target (140/90 mm Hg or less) do not outweigh the harms associated with that intervention.”
12 Jan, 2021 | 01:30h | UTCBlood pressure targets in adults with hypertension – Cochrane Library
Summary: The use of lower blood pressure targets for people with hypertension – Cochrane Library
Related systematic review: Blood pressure targets in people with cardiovascular disease – Cochrane Library
Commentary on Twitter
The use of lower #bloodpressure targets for people with #hypertension https://t.co/W1bF8W7CDD Updated @CochraneHTN systematic review includes 11 randomised controlled trials involving 38,688 adult participants.
— Cochrane (@cochranecollab) December 30, 2020